Clinical Trial Update: Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the pharmacokinetics and safety of oxcarbazepine extended-release as adjunctive therapy in pediatric patients with partial epilepsy; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Drugs mentioned

• OXTELLAR XR (oxcarbazepine)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Epilepsies, Partial | Phase 1 | Status: COMPLETED